Stryker (SYK) Total Debt Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.40% |
| Dec 31, 2025 | 2.54% |
| Sep 30, 2025 | 4.80% |
| Jun 30, 2025 | 5.11% |
| Mar 31, 2025 | 9.82% |
| Dec 31, 2024 | 4.16% |
| Sep 30, 2024 | 12.97% |
| Jun 30, 2024 | 7.50% |
| Mar 31, 2024 | 8.72% |
| Dec 31, 2023 | 5.68% |
| Sep 30, 2023 | 11.99% |
| Jun 30, 2023 | 12.45% |
| Mar 31, 2023 | 10.57% |
| Dec 31, 2022 | 12.56% |
| Sep 30, 2022 | 12.05% |
| Jun 30, 2022 | 12.68% |
| Mar 31, 2022 | 14.33% |
| Dec 31, 2021 | 12.54% |
| Sep 30, 2021 | 13.06% |
| Jun 30, 2021 | 10.76% |
| Mar 31, 2021 | 11.83% |
| Dec 31, 2020 | 28.47% |
| Sep 30, 2020 | 30.40% |
| Jun 30, 2020 | 30.08% |
| Mar 31, 2020 | 24.72% |
| Dec 31, 2019 | 22.79% |
| Sep 30, 2019 | 16.26% |
| Jun 30, 2019 | 17.10% |
| Mar 31, 2019 | 22.55% |
| Dec 31, 2018 | 28.96% |
| Sep 30, 2018 | 21.03% |
| Jun 30, 2018 | 21.05% |
| Mar 31, 2018 | 23.31% |
| Dec 31, 2017 | 32.60% |
| Sep 30, 2017 | 32.50% |
| Jun 30, 2017 | 33.06% |
| Mar 31, 2017 | 32.41% |
| Dec 31, 2016 | 31.36% |
| Sep 30, 2016 | 30.93% |
| Jun 30, 2016 | 49.57% |
| Mar 31, 2016 | 48.80% |
| Dec 31, 2015 | 31.39% |
| Sep 30, 2015 | 27.95% |
| Jun 30, 2015 | 27.86% |
| Mar 31, 2015 | 27.74% |
| Dec 31, 2014 | 194.29% |
| Sep 30, 2014 | 193.80% |
| Jun 30, 2014 | 188.35% |